(Q33271635)

25 July 2017

title

SELDI-TOF MS profiling of plasma proteins in ovarian cancer (English)

1 reference

25 July 2017

1 reference

Shao-Pai Wu

1

1 reference

25 July 2017

Ya-Wen Lin

2

1 reference

25 July 2017

Hung-Cheng Lai

3

1 reference

25 July 2017

Tang-Yuan Chu

4

1 reference

25 July 2017

Yu-Liang Kuo

5

1 reference

25 July 2017

Hang-Seng Liu

6

1 reference

25 July 2017

publication date

1 March 2006

1 reference

Taiwanese Journal of Obstetrics & Gynecology

25 July 2017

published in

1 reference

25 July 2017

volume

45

1 reference

25 July 2017

issue

1

1 reference

25 July 2017

page(s)

26-32

1 reference

The influence of tumor grade, distribution, and extent of carcinomatosis in minimal residual stage III epithelial ovarian cancer after optimal primary cytoreductive surgery

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2809%2960186-8

7 January 2021

Surgical management of ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2809%2960186-8

7 January 2021

Screening for ovarian cancer: a pilot randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2809%2960186-8

7 January 2021

Progress and challenges in screening for early detection of ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2809%2960186-8

7 January 2021

Recent developments in ovarian cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2809%2960186-8

7 January 2021

Three-dimensional power Doppler ultrasound improves the diagnostic accuracy for ovarian cancer prediction

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2809%2960186-8

7 January 2021

A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2809%2960186-8

7 January 2021

Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2809%2960186-8

7 January 2021

Osteopontin as a potential diagnostic biomarker for ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2809%2960186-8

7 January 2021

Comparative hybridization of an array of 21,500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2809%2960186-8

7 January 2021

Use of proteomic patterns in serum to identify ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2809%2960186-8

7 January 2021

Use of proteomic analysis to monitor responses to biological therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2809%2960186-8

7 January 2021

A research-based tumor tissue bank of gynecologic oncology: characteristics of nucleic acids extracted from normal and tumor tissues from different sites

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2809%2960186-8

7 January 2021

Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2809%2960186-8

7 January 2021

SELDI-TOF serum profiling for prognostic and diagnostic classification of breast cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2809%2960186-8

7 January 2021

Putative protein markers in the sera of men with prostatic neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2809%2960186-8

7 January 2021

Serum protein expression profiling for cancer detection: validation of a SELDI-based approach for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2809%2960186-8

7 January 2021

The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2809%2960186-8

7 January 2021

Identification of gastric cancer patients by serum protein profiling

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2809%2960186-8

7 January 2021

Proteomics and cancer diagnosis: the potential of mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2809%2960186-8

7 January 2021

Proteomic approaches within the NCI early detection research network for the discovery and identification of cancer biomarkers.

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2809%2960186-8

7 January 2021

Detection of differentially expressed proteins in early-stage melanoma patients using SELDI-TOF mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2809%2960186-8

7 January 2021

SELDI proteinchip MS: a platform for biomarker discovery and cancer diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2809%2960186-8

7 January 2021

Proteomic approaches to the diagnosis, treatment, and monitoring of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2809%2960186-8

7 January 2021

Proteomic patterns: their potential for disease diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2809%2960186-8

7 January 2021

Protein expression profiling of endometrial malignancies reveals a new tumor marker: chaperonin 10

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2809%2960186-8

7 January 2021

New serum biomarkers for detection of HBV-induced liver cirrhosis using SELDI protein chip technology

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2809%2960186-8

7 January 2021

An integrated approach to the detection of colorectal cancer utilizing proteomics and bioinformatics

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2809%2960186-8

7 January 2021

Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: potential use in diagnosis and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2809%2960186-8

7 January 2021

Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2809%2960186-8

7 January 2021

beta-Amyloid peptide vaccination results in marked changes in serum and brain Abeta levels in APPswe/PS1DeltaE9 mice, as detected by SELDI-TOF-based ProteinChip technology

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2809%2960186-8

7 January 2021

The use of seldi proteinchip arrays to monitor production of Alzheimer's betaamyloid in transfected cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2809%2960186-8

7 January 2021

Immunology. Versatile defensins

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2809%2960186-8

7 January 2021

10.1016/S1028-4559(09)60186-8

Identifiers

DOI

0 references

1 reference